Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-003454
Filing Date
2025-02-11
Accepted
2025-02-11 18:51:06
Documents
1
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5746
  Complete submission text file 0001437749-25-003454.txt   7297
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
AUERBACH ALAN H (Reporting) CIK: 0001358285 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 25611369

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)